Potential new therapeutic for Relapsing MS patients

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Potential new therapeutic for Relapsing MS patients

Postby MSUK » Fri Feb 19, 2016 3:02 am

RADIANCE phase 2 trial of ozanimod, an investigational selective S1P 1 and 5 receptor modulators for relapsing multiple sclerosis (MS) patients results showed significant reductions in the cumulative number of total gadolinium-enhancing (GdE) lesions...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2853
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service